Search

everythinglearnresearchcommunity

for

Search:↓

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Topical tacrolimus is effective and safe for treating alopecia areata.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The procedure effectively created natural-looking hairlines and improved facial balance in female patients.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Arab hair is generally thicker but less dense compared to other ethnicities, affecting hair disorder diagnosis and treatment.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.